Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014	[1]
Current assets:
Cash and cash equivalents ($7,700 and $7,202 related to VIEs)	$ 47,793	$ 99,167
Restricted cash	80	7,051
Marketable securities	622
Accounts receivable, net ($21,036 and $13,799 related to VIEs)	149,224	137,807
Prepaid expenses ($559 and $651 related to VIEs)	9,381	8,728
Inventories ($344 and $370 related to VIEs)	5,162	4,526
Deferred income taxes ($6 and $6 related to VIEs)	191	227
Other ($367 and $403 related to VIEs)	8,056	7,457
Total current assets	220,509	264,963
Equity investments in joint ventures	1,236	1,646
Property and equipment, net ($22,412 and $19,051 related to VIEs)	249,392	270,757
Real estate subject to finance obligation	11,625	22,552
Goodwill ($52,454 and $54,377 related to VIEs)	492,084	469,596
Intangible assets, net ($6,083 and $12,421 related to VIEs)	74,434	81,680
Other assets ($6,261 and $6,335 related to VIEs)	49,282	35,530
Total assets	1,098,562	1,146,724
Current liabilities:
Accounts payable ($2,965 and $1,270 related to VIEs)	59,397	57,635
Accrued expenses ($2,467 and $3,534 related to VIEs)	140,061	82,609
Income taxes payable ($0 and $0 related to VIEs)	1,814	2,114
Current portion of long-term debt ($62 and $14 related to VIEs)	30,858	26,350
Current portion of finance obligation	481	433
Other current liabilities	6,484	19,687
Total current liabilities	239,095	188,828
Long-term debt, less current portion ($174 and $11 related to VIEs)	1,009,196	940,771
Finance obligation, less current portion	12,057	23,610
Embedded derivative and other financial instrument features of Series A convertible redeemable preferred stock	27,339	15,843
Other long-term liabilities ($2,830 and $2,474 related to VIEs)	39,861	51,079
Deferred income taxes	3,716	4,480
Total liabilities	1,331,264	1,224,611
Series A convertible redeemable preferred stock, $0.001 par value, $1,000 stated value, 3,500,000 authorized, 385,000 issued and outstanding at September 30, 2015 and December 31, 2014, respectively	370,478	328,926
Noncontrolling interests - redeemable	$ 19,934	$ 15,273
Commitments and contingencies
Equity:
Common stock, $0.01 par value, 1,000,000 shares authorized, 1,059 and 1,028 issued and outstanding at September 30, 2015 and December 31, 2014, respectively
Additional paid-in capital	$ 599,733	$ 626,001
Retained deficit	(1,204,171)	(1,067,487)
Accumulated other comprehensive loss, net of tax	(45,008)	(38,690)
Total 21st Century Oncology Holdings, Inc. shareholder's deficit	(649,446)	(480,176)
Noncontrolling interests - nonredeemable	26,332	58,090
Total deficit	(623,114)	(422,086)
Total liabilities and equity	$ 1,098,562	$ 1,146,724

[1] Derived from audited financial statements.